Petrova, Pietras, K., Pili, R., Pollard, J.W., Post, M.J., Quax, P.H.A., Rabinovich, G.A., Raica, M., Randi, A.M., Ribatti, D., Ruegg, C., Schlingemann, R.O., Schulte-Merker, S., Smith, L.E.H., Song, J.W., Stacker, S.A., Stalin, J., Stratman, A.N., Van de Velde, M., van Hinsbergh, V.W.M., Vermeulen, P.B., Waltenberger, J., Weinstein, B.M., Xin, H., Yetkin-Arik, B., Yla-Herttuala, S., Yoder, M.C., and Griffioen, A.W., "Consensus guidelines for the use and interpretation of angiogenesis assays", Angiogenesis 21 (3): 425-532 (2018)
The AOD-9604 treatment groups demonstrated measurable improvements across these parameters, suggesting genuine tissue regeneration rather than merely symptomatic relief
Stimuli-responsive nanomedicines for overcoming cancer multidrug resistance
(no photo available) 96 tests $974 KT-61439 a-glutathione S-transferases ELISA Kit (A-GST), Human For quantitative detection in human samples